Physician profile
Eli Azzi
NPI 1770548786
$238.07
in general payments reported to CMS, 2019-2025
8 companies · $66.40 in 2025
The $66.40 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.55 · 2023: $27.25 · 2024: $122 · 2025: $66.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $71.93 | 2024 | Xt Cdx |
| Janssen Pharmaceuticals, INC | $35.28 | 2024 | Xarelto |
| Abiomed | $31.06 | 2025 | |
| Fisher & Paykel Healthcare INC | $27.25 | 2023 | Fisher & Paykel Healthcare |
| Pfizer INC. | $22.55 | 2019 | |
| Ethicon INC. | $17.98 | 2025 | Monarch Platform |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.36 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $14.66 | 2024 | Recarbrio, Zerbaxa, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Azzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.